Clinical Trials Directory

Trials / Completed

CompletedNCT05075941

Evaluation of Vaccination Coverage and Determinants of Success of the COVID-19 Vaccination Program Among Populations in Very Precarious Situations

PREVAC: Evaluation of Vaccination Coverage and Determinants of Success of the COVID-19

Status
Completed
Phase
Study type
Observational
Enrollment
3,811 (actual)
Sponsor
Epicentre · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

The main objective of the study is to assess the level of vaccination coverage (VC) against COVID-19 among migrants, homeless and travelling community, according to their living conditions and housing. The secondary objectives are : * to compare the estimated level of vaccination coverage in the different sites and strata (emergency shelters/hotels, camps, workers' hostels, on the street) with the estimated level in the general population of the same territory obtained from the French Health Insurance data (SIVAC). * identify the obstacles and leverage of vaccination (i.e. mobile team) according to living conditions and habitat (socio-demographic factors, personal health history, vaccine adherence, local health policies, etc.).

Conditions

Interventions

TypeNameDescription
OTHERVaccination coverageproportion of people declaring to have received at least one dose of vaccination against COVID-19 among target population

Timeline

Start date
2021-11-15
Primary completion
2021-12-22
Completion
2021-12-22
First posted
2021-10-13
Last updated
2023-04-06

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT05075941. Inclusion in this directory is not an endorsement.